Skip to main content
L

Limula

Limula provides a modular, automated platform that integrates a bioreactor and centrifuge for the on-demand, at-scale manufacturing of cell therapies. This technology addresses the high costs and complexity of producing personalized cell therapies, enabling efficient processing of various cell types in a single device.

La Tour-de-Peilz, SwitzerlandFounded 2020265K+ followers
Updated 20 months ago

Funding

$13.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FF
Funding rounds are not available yet.

Founders

Product

Problem

Manufacturing personalized cell therapies is complex and expensive, hindering widespread access to these potentially life-saving treatments. Current manufacturing processes struggle to efficiently produce cell therapies at the scale needed to meet global demand.

Solution

Limula offers a modular, automated platform designed to streamline and scale the manufacturing of cell therapies. Their system integrates a bioreactor and centrifuge into a single device, enabling efficient processing of various cell types with minimal human intervention. This integrated approach reduces the complexity and cost associated with traditional cell therapy manufacturing. The platform's modular design allows for stepwise development of an end-to-end manufacturing solution, building upon their core cell processing unit with additional modules. The unique bioreactor shape facilitates scale-down for process development and scale-up/out for commercial-stage manufacturing.

Target Audience

Limula's primary customers are cell and gene therapy developers and manufacturers seeking to automate and scale their production processes.

Features

  • Integrated bioreactor and centrifuge for automated cell processing
  • Modular design for flexible and scalable manufacturing
  • Proprietary bioreactor design optimized for cell therapy applications
  • In-situ centrifugation enabling complex cell processing steps in a single container
  • User-friendly software interface for intuitive operation and low hands-on time
  • Potential to support a variety of cell types, including T cells and hematopoietic stem cells
This profile is AI-generated and may contain inaccuracies.